A complete application in a minute
Tailored resume and cover letter, ready to send.
Alpha-9 Oncology seeks a Director of Program Management to drive planning and execution across the radiopharmaceutical pipeline. You will own integrated development plans and coordinate Clinical, Regulatory, CMC, and nonclinical teams to balance quality, speed, and cost.
This hands-on leadership role requires digging into details, raising risks early, and building relationships to keep milestones on track and budgets in check. Strong program management expertise is essential.
Alpha-9 Oncology is seeking a Director, Program Management to join the clinical team to drive planning and execution across our radiopharmaceutical pipeline. Our programs target solid and hematologic malignancies, and with clinical studies now underway, this role brings the structure that keeps programs on time, in scope, and within budget.
Working alongside our program leads and functional experts, you’ll build and own the integrated plans that connect Clinical, Regulatory, CMC, and nonclinical teams. Program strategy and clinical decisions sit with the program leads. Your role is to frame the options, balance quality, speed, and cost, and guide the team to clear decisions, then make sure those decisions are carried through. This is a hands‑on role for someone who digs into the details, raises risks early, and builds trusted relationships across the company to keep work moving.
At Alpha-9 Oncology, we offer a competitive and comprehensive benefits package designed to support all employees.
tailored to local standards in each region.
Alpha-9 Oncology is a clinical‑stage biotechnology company pioneering radiopharmaceutical innovation for solid tumors. Our proprietary scaffolds, composed of optimized binders, linkers, chelators, and radioisotopes, enable targeted radiation delivery to cancer cells, minimizing harm to surrounding healthy tissue. Focusing on innovative targeting moieties, we develop molecules tailored for precise tumor targeting.
Our comprehensive platform integrates imaging and therapeutic studies to ensure effective radiation delivery and improved patient outcomes. With a robust pipeline entering clinical trials and strong support from leading healthcare investors, Alpha‑9 is positioned for rapid growth and advancement in cancer therapy.
Alpha-9 Oncology is committed to fostering a diverse and inclusive workplace and is proud to be an Equal Opportunity Employer. We provide employment opportunities to all qualified applicants without regard to race, ethnicity, religion, age, sex, gender identity or expression, sexual orientation, disability, marital status, family status, national origin, or any other characteristic protected by applicable federal, provincial, or local laws where we operate.
We are dedicated to providing reasonable accommodations to qualified applicants and employees to ensure that everyone can perform their essential job functions in an inclusive environment. For inquiries regarding accommodations in the hiring process or for current employees, please contact a member from our Talent Acquisition team.
For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.
As set forth in Alpha‑9 Oncology’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.
If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:
A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service‑connected disability.
A "recently separated veteran" means any veteran during the three‑year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.
An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.
An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.